Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PRF vs FDBA for Alveolar Ridge Preservation
NCT03331185Phase 3Completed
- Sponsor
- University of Manitoba
- Start
- Jan 2018
- Primary completion
- Apr 2019
- Modality
- Device-based Delivery
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of platelet rich fibrin in Alveolar bone loss (2 arms), sponsored by University of Manitoba. Primary endpoint: Overall Horizontal Change in Alveolar Ridge Width at 11 weeks. Started Jan 2018; status: completed.
02
Drugs
platelet rich fibrin
03
Conditions
Alveolar bone loss
Beyond the preview
Go deeper on NCT03331185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03331185.